| # | Drug | Count |
|---|---|---|
| 0 | VALPROATE SODIUM | 14 |
| 1 | DIAZEPAM | 13 |
| 2 | DIAZEPAM ORAL | 13 |
| 3 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 13 |
| 4 | HYDROXYZINE | 13 |
| 5 | POTASSIUM CHLORIDE | 11 |
| 6 | POTASSIUM CHLORIDE EXTENDED-RELEASE | 11 |
| 7 | POTASSIUM CHLORIDE ORAL | 11 |
| 8 | POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE | 11 |
| 9 | ALBUTEROL SULFATE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DINUTUXIMAB | 1 | 0.0012 |
| 1 | VALPROATE SODIUM | 14 | 0.0007 |
| 2 | HYDROXYZINE | 13 | 0.0003 |
| 3 | DESMOPRESSIN ACETATE | 1 | 0.0003 |
| 4 | AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | 1 | 0.0002 |
| 5 | DIAZEPAM ORAL | 13 | 0.0001 |
| 6 | LAMIVUDINE AND ZIDOVUDINE | 1 | 0.0001 |
| 7 | OXCARBAZEPINE | 2 | 0.0001 |
| 8 | GUANFACINE | 1 | 0.0001 |
| 9 | POTASSIUM CHLORIDE ORAL | 11 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 13 |
| 1 | Osmotic Laxative [EPC] | 11 |
| 2 | Potassium Salt [EPC] | 11 |
| 3 | Anti-epileptic Agent [EPC] | 5 |
| 4 | Interleukin-4 Receptor alpha Antagonist [EPC] | 3 |
| 5 | Mood Stabilizer [EPC] | 3 |
| 6 | Partial Opioid Agonist [EPC] | 3 |
| 7 | Central Nervous System Stimulant [EPC] | 2 |
| 8 | Corticosteroid [EPC] | 2 |
| 9 | Leukotriene Receptor Antagonist [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 1 | Leukotriene Receptor Antagonist [EPC] | 2 | 0.0001 |
| 2 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 3 | Osmotic Laxative [EPC] | 11 | 0.0000 |
| 4 | Partial Opioid Agonist [EPC] | 3 | 0.0000 |
| 5 | Soluble Guanylate Cyclase Stimulator [EPC] | 1 | 0.0000 |
| 6 | Central Nervous System Stimulant [EPC] | 2 | 0.0000 |
| 7 | Anti-epileptic Agent [EPC] | 5 | 0.0000 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Benzodiazepine [EPC] | 13 | 0.0000 |